The ORVAC trial: A phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: A statistical analysis plan
Mark A. Jones, Todd Graves, Bianca Middleton, James Totterdell, Thomas L. Snelling, Julie A. Marsh
Research output: Contribution to journal › Article › peer-review
2
Link opens in a new tab
Citations
(Scopus)
94
Downloads
(Pure)